Demographic profile and clinical outcomes in stable patients transfused with RBCs
Variables . | Pre-BPA . | Post-BPA . | P . |
---|---|---|---|
No. of patients | 3622 | 10 528 | |
Age, y | 59.7 ± 17.4 | 59.8 ± 17 | .76 |
% Female | 54.3 | 50.2 | .0001 |
Case mix index | 2.78 | 2.86 | .0001 |
RBC units transfused | 3.6 ± 4.1 | 2.7 ± 3.0 | .0001 |
Length of stay, d | 10.1 ± 13.3 | 6.2 ± 10.2 | .0001 |
% Mortality | 5.5 | 3.3 | .0001 |
% 30-day readmission | 13.7 | 8.5 | .0001 |
Discharge Hb, g/dL | 9.9 | 9.0 | .0001 |
Variables . | Pre-BPA . | Post-BPA . | P . |
---|---|---|---|
No. of patients | 3622 | 10 528 | |
Age, y | 59.7 ± 17.4 | 59.8 ± 17 | .76 |
% Female | 54.3 | 50.2 | .0001 |
Case mix index | 2.78 | 2.86 | .0001 |
RBC units transfused | 3.6 ± 4.1 | 2.7 ± 3.0 | .0001 |
Length of stay, d | 10.1 ± 13.3 | 6.2 ± 10.2 | .0001 |
% Mortality | 5.5 | 3.3 | .0001 |
% 30-day readmission | 13.7 | 8.5 | .0001 |
Discharge Hb, g/dL | 9.9 | 9.0 | .0001 |
Values are mean (± standard deviation) if available. Procedural areas (eg, operating room, cardiac catheterization laboratory) were excluded along with patients who had discharge diagnoses or problem lists that include hemorrhage.31